Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...
Libtayo is also used to treat two forms of skin cancer – cutaneous squamous cell carcinoma and basal cell carcinoma. Merck claims adjuvant win in melanoma There was good news for Merck in ...
IVIEW Therapeutics Inc., a clinical-stage biotechnology company dedicated to advancing innovative treatments for ocular diseases, today announced positive topline data from its Phase 1/2 clinical ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Nearly two months after Randy Moss underwent surgery following his cancer diagnosis, the ESPN commentator made an appearance virtually at the 2025 NFL Honors to present an award.
A single-center study suggests the surgery is safe and effective even when tumors are large or located in high-risk areas.
UCR scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers ...
Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the ...
Nearly two months after Randy Moss underwent surgery following his cancer diagnosis, the ESPN commentator made an appearance virtually at the 2025 NFL Honors to present an award.
Feb. 7, 2025 — Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to ... Personalized Cancer ...
These vaccines are sometimes tested in combination with established cancer drugs. During CAR T-cell therapy, T-cells are extracted and modified to add a receptor to their surface. This helps the T ...
WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Patients with hematologic malignancies, especially those with chronic lymphocytic leukemia (CLL), have an increased risk for developing skin cancer, ...